Vascular Disease and Thrombosis

Loading the player...

DECLARE-TIMI 58 Commentary

Eric Peterson, MD, chair of the program committee for Scientific Sessions 2018, comments on the results of the DECLARE TIMI 58 trial which was presented at the meeting in Chicago this year.
 

AHA / ASA Professional Members are Difference Makers.

 

Related Councils

Council on Peripheral Vascular Disease (PVD)

Naomi Hamburg, MD, MS, FAHA

The Council on Peripheral Vascular Disease (PVD) is a vibrant, interdisciplinary council whose members are focused on improving the care of patients with vascular diseases through advancing science, education, advocacy, and improved healthcare delivery. To achieve our goals within the American Heart Association we need to continue to grow our membership and foster their active involvement in all of our educational programs and scientific initiatives. This means we need you!

Naomi Hamburg, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease

Vascular Discovery Scientific Sessions       Circulation       PVD Council Awards

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Mary Sorci-Thomas, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Mary Sorci-Thomas, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Vascular Discovery Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Clinical Cardiology (CLCD)

Eldrin Lewis, MD, MPH, FAHA, FACC

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Eldrin Lewis, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR)

Fumito Ichinose, MD, PhD, FAHA

The American Heart Association's (AHA) strategic goal to reduce coronary heart disease, stroke and risk by 20 percent by the year 2020 has led to an emphasis on the importance of resuscitation and the chain of survival in AHA activities and use of resources. The Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) bench-to-bedside and community approach ranges from integrated cardiopulmonary physiology to issues of critical care, emergency cardiovascular care and CPR. Pulmonary hypertension and regulation of the pulmonary circulation have historically been areas of investigation for many of our council members. The council is keenly interested in promoting approaches that include clinical care, clinical research and basic science.

This is an exciting time for the 3CPR Council; the past few years have seen growth in our membership and new programs, including the formation of a robust Early Career Committee and inclusion of pre-hospital providers into our activities and programming.

Fumito Ichinose, MD, PhD, FAHA
Chair, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

Resuscitation Science Symposium       Scientific Sessions       Circulation       3CPR Council Awards